MEDNAX, Inc. Forecast, price target & analysts
MEDNAX, Inc. Target price 2026 - Analyst rating & recommendation
MEDNAX, Inc. Classifications & Recommendation
MEDNAX, Inc. Price Target
| Target Price | $28.56 |
| Price | $25.93 |
| Potential |
10.14%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target MEDNAX, Inc. 2027 .
The average MEDNAX, Inc. target price is $28.56.
This is
10.14%
register free of charge
$29.40
13.38%
register free of charge
$21.21
18.20%
register free of charge
|
|
| A rating was issued by 15 analysts: 8 Analysts recommend MEDNAX, Inc. to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MEDNAX, Inc. stock has an average upside potential 2027 of
10.14%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.91 | 2.02 |
| 4.92% | 5.55% | |
| EBITDA Margin | 13.21% | 14.80% |
| 23.20% | 12.00% | |
| Net Margin | 8.64% | 9.73% |
| 275.58% | 12.59% |
10 Analysts have issued a sales forecast MEDNAX, Inc. 2026 . The average MEDNAX, Inc. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an MEDNAX, Inc. EBITDA forecast 2026. The average MEDNAX, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 MEDNAX, Inc. Analysts have issued a net profit forecast 2026. The average MEDNAX, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.94 | 2.42 |
| 263.03% | 24.74% | |
| P/E | 10.88 | |
| EV/Sales | 1.15 |
10 Analysts have issued a MEDNAX, Inc. forecast for earnings per share. The average MEDNAX, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current MEDNAX, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | Aug 19 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| UBS |
Locked
➜
Locked
|
Locked | May 12 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 13 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Feb 24 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Feb 20 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
Aug 19 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jul 14 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
May 12 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 13 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Feb 24 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Feb 20 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
